EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antidiabetic Effects of Ecklonia cava and Dieckol via DPP-IV Inhibition and Glucose Transport Regulation

Indyaswan T Suryaningtyas, Nabila Shafura iD, Ratih Pangestuti iD, Won-Kyo Jung iD, Jae-Young Je iD

Marine Drugs · 12.05.2026 · 24 (5) · 174

DOI: 10.3390/md24050174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 12.05.2026. Verfasst von Indyaswan T Suryaningtyas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Marine-Integrated Bionics Technology, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Benzofurans, Phaeophyceae, Hypoglycemic Agents, Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pukyong National University, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brown seaweeds are recognized for their rich content of phlorotannins with promising antidiabetic properties through multi-targeted modulation of glucose metabolism. This study investigated the antidiabetic potential of the ethyl acetate fraction of Ecklonia cava (EC-ETAC) and its major phlorotannin, dieckol, focusing on inhibition of carbohydrate-digesting enzymes, intestinal glucose absorption, dipeptidyl peptidase-IV (DPP-IV) activity, and hepatic glucose metabolism. EC-ETAC potently inhibited α-glucosidase (IC50 = 2.2 ± 0.2 µg/mL) and α-amylase (IC50 = 41.0 ± 1.2 µg/mL), outperforming acarbose by 26-fold and 6-fold, respectively. Pure dieckol showed strong activity with IC50 values of 2.213 ± 0.04 µM (α-glucosidase) and 156.87 ± 0.124 µM (α-amylase). In differentiated Caco-2 cells, both EC-ETAC and dieckol downregulated SGLT1 and GLUT2 protein expression to ~0.5-fold of control and suppressed 2-NBDG glucose uptake by 46–53% over 120 min, effects not seen with acarbose. Dieckol inhibited DPP-IV activity (IC50 = 12.12 ± 0.021 µM), reducing in situ activity to 53.89% at 25 µM without changing DPP-IV protein levels. Molecular docking revealed high-affinity binding of dieckol to DPP-IV (−10.396 kcal/mol), directly occluding the catalytic triad (Ser630, His740). In insulin-resistant HepG2 cells, dieckol restored glucose uptake to 108.97% of control via AMPK activation (1.21-fold), GLUT2 normalization (0.84-fold), and PGC-1α recalibration (0.96-fold), matching or surpassing 1 mM metformin. These results demonstrate dual-inhibition mechanism combined with hepatic AMPK restoration, establishing dieckol as a promising marine-derived multi-targeted agent for T2DM management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzofuransPhaeophyceaeHypoglycemic AgentsGlucoseDipeptidyl-Peptidase IV InhibitorsHumansCaco-2 CellsDipeptidyl Peptidase 4Animalsalpha-AmylasesBiological TransportSeaweed

Stichwörter der Autor:innen

AMPKDPP-IVEcklonia cavadieckolglucose transportersphlorotanninstype 2 diabetes

Substanzen

BenzofuransdieckolHypoglycemic AgentsGlucoseDipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4alpha-Amylases

Autor:innen und Institutionen

  • Research Center for Marine-Integrated Bionics Technology, Pukyong National University, Busan 48513, Republic of Korea.
  • Research Center for Food Technology and Processing, National Research and Innovation Agency (BRIN), Yogyakarta 55861, Indonesia.
  • Major of Human Bioconvergence, Division of Smart Healthcare, Pukyong National University, Busan 48513, Republic of Korea.
  • Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan 48513, Republic of Korea.
  • Major of Biomedical Engineering, Division of Smart Healthcare, College of Information Technology and Convergence and New-Senior Healthcare Innovation Center (BK21 Plus), Pukyong National University, Busan 48513, Republi…

ORCID-Profile: Nabila Shafura, Ratih Pangestuti, Won-Kyo Jung, Jae-Young Je

Förderung

  • Pukyong National University
  • National Research Foundation

Zitieren

APA

Suryaningtyas, I. T., Shafura, N., Pangestuti, R., Jung, W. K., & Je, J. Y. (2026). Antidiabetic Effects of Ecklonia cava and Dieckol via DPP-IV Inhibition and Glucose Transport Regulation. Marine Drugs, 24(5), 174. https://doi.org/10.3390/md24050174

Vancouver

Suryaningtyas IT, Shafura N, Pangestuti R, Jung WK, Je JY. Antidiabetic Effects of Ecklonia cava and Dieckol via DPP-IV Inhibition and Glucose Transport Regulation. Marine Drugs. 2026;24(5):174. doi:10.3390/md24050174

BibTeX
@article{Suryaningtyas2026,
  author = {Suryaningtyas, Indyaswan T and Shafura, Nabila and Pangestuti, Ratih and Jung, Won-Kyo and Je, Jae-Young},
  title = {Antidiabetic Effects of Ecklonia cava and Dieckol via DPP-IV Inhibition and Glucose Transport Regulation},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {174},
  doi = {10.3390/md24050174}
}
Kostenlos starten →